Delayed optimization was independently associated with adverse outcomes in cohorts receiving excessive empiric therapy. These findings emphasize the importance of prompt de-escalation of broad-spectrum antibiotics to mitigate treatment failure and treatment discontinuation attributable to adverse events.
Niinuma et al. (Mon,) studied this question.